Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. MSFT
6. NVDA
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)

November 2, 2016 6:56 AM EDT

(Updated - November 2, 2016 7:17 AM EDT)

(Gilead was not upgraded to Outperform, remains Market Perform at BMO.)

BMO Capital maintained its Market Perform rating on Gilead Sciences (NASDAQ: GILD) with a price target of $84 (prior $98). Comments follow Q3 results.... More

Gilead Sciences (GILD) Declares $0.47 Quarterly Dividend; 2.5% Yield

November 1, 2016 4:04 PM EDT

Gilead Sciences (NASDAQ: GILD) declared a quarterly dividend of $0.47 per share, or $1.88 annualized.

The dividend will be payable on December 29, 2016, to stockholders of record on December 15, 2016, with an ex-dividend date of December 13, 2016.

The annual yield on the dividend is 2.5... More